Breye Therapeutics

Series-A
breye.com Biotech & Healthcare Hørsholm, Denmark Founded 2022 11-50
Total Funding $80.8M
Latest Round $76.6M Series-A
Last Announced Sep 29, 2026
Investors 10 Backers
Decision Makers 1 Verified

About Breye Therapeutics

Breye Therapeutics develops oral medicines for retinal diseases, with a focus on diabetic retinopathy and age-related macular degeneration.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Hørsholm, Denmark
Year Founded 2022
Team Size 11-50
Tracked Since Oct 4, 2026

Web & Domain Identity

Official Website breye.com
Domain Registered Date May 4, 2005

Social & Network Presence

X / Twitter Profile @companies
LinkedIn Corporate Company Profile

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $76,650,000 · Series-A

    Backed by Mission BioCapital, Novo Holdings

  2. Capital Raise

    Raised $4,120,000 · Seed

    Backed by Novo Holdings, Sound Bioventures

  3. Milestone

    Company founded

    Hørsholm, Denmark

  4. Milestone

    Website domain registered

    breye.com

Investors & Backers

10
Catalyze Capital
Export and Investment Fund
Innovestor
Mission BioCapital
Modi Ventures
Novo Holdings
Pappas Capital
Sound Bioventures
The Ljungstrom Family Office
Vaekstfonden

Funding History

2 Rounds
Series-A equity · Sep 29, 2026

Round backers: Mission BioCapital, Novo Holdings, Catalyze Capital, Export and Investment Fund, Innovestor, Modi Ventures, Pappas Capital, Sound Bioventures, The Ljungstrom Family Office

Seed equity · Nov 11, 2022

Round backers: Novo Holdings, Sound Bioventures

$4,120,000 finsmes.com

Founders & Leadership

1

Ulrik Mouritzen

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts